Has David Koven, DO received payments from drug or device companies?

Yes. Drug and device makers reported $463 in general payments to David Koven, DO across 12 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Koven, DO did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Koven, DO come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Koven, DO

Psychiatry · Monterey, CANPI 1780189639

Payments from drug & device makers

$463in general payments, 2019–2025

Across 12 payments — averaging $38.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Otsuka America Pharmaceutical, Inc.$149
Otsuka Pharmaceutical Development & Commercialization, Inc.$130
AbbVie$62
Alkermes, Inc.$29
Neurocrine Biosciences, Inc.$27
Indivior Inc.$26
plus $40 from 2 others

What the payments were for

Food & beverage$463100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Otsuka America Pharmaceutical, Inc.	3	$149
Otsuka Pharmaceutical Development & Commercialization, Inc.	2	$130
AbbVie	2	$62
Alkermes, Inc.	1	$29
Neurocrine Biosciences, Inc.	1	$27
Indivior Inc.	1	$26
Teva Pharmaceuticals USA, Inc.	1	$25
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ABILIFY MAINTENA$214

How this compares

$463 in reported general payments places this provider in the 65th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California →

Medicare billing

Part B allowed, 2024

$93,700

Medicare patients

212

Services billed

833

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Olanzapine	32	$702
Hydroxyzine Pamoate	14	$152
Quetiapine Fumarate	14	$136
Trazodone Hcl	26	$123
Gabapentin	21	$107

Paid to pharmacies, not to this prescriber.

Other psychiatry in Monterey

Elly LeeIrvine$49.8M
Daniel ChuehOrange$17.9M
Eric ChavezSan Diego$15.5M
Lara ShirikjianTorrance$12.6M
John DuffySanta Ana$12M
Marina BusselPlaya Vista$12M
Sherry SoefjeOceanside$11.9M
Steven MacinaHuntington Beach$11.1M
Wakelin McNeelRosemead$11M
Donald AndersonBanning$10.5M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →